Reporter brief
Narrative review summarizes diagnostic criteria and treatment evidence for hypogonadism in aging men with comorbidities
What happened
This narrative review examined the prevalence, diagnosis, and management of male hypogonadism in older men, particularly in the context of obesity and cardiometabolic disorders. The authors searched PubMed for relevant literature on hypogonadism, aging, obesity, diabetes, and related comorbidities, selecting original research articles, systematic reviews, meta-analyses, and clinical guidelines. The review addresses unresolved questions about diagnostic thresholds, the relationship between testosterone decline and aging, and the impact of treatment on symptoms and long-term health outcomes in older men.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Systematic review; Human.
Aging men, with particular focus on those with obesity, type 2 diabetes mellitus, and other cardiometabolic comorbidities (functional hypogonadism), and comparison to younger men with congenital or acquired disorders affecting the hypothalamic-pituitary-testicular axis (organic hypogonadism)
- Design
- Systematic review
- Sample
- —
- Journal
- Maturitas
- Published
- Sep 9, 2026
Effect size
Not recorded.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Testosterone therapy timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.